February 19th, 2008 by Richard Brassaw
Depression is often accompanied with a sense of hopelessness, which sometimes leads a patient to discontinue taking their antidepressant medication.
James E. Aikens, PhD, associate professor of Family Medicine, University of Michigan Health System, studied 573 depressed patients from 37 different practices. The patients were given one of the antidepressants: fluoxetine (Prozac), paroxetine (Paxil), or sertraline [...]
February 18th, 2008 by Richard Brassaw
Patients with Parkinson’s, Alzheimer’s, and Huntinton’s diseases have been found to have deposits of iron in their brain. It is thought that these ‘iron’ deposits are caused by the collapse of the transport system that safely moves iron through our blood stream.
Peter Sadler, Professor, University of Warwick, and Sandeep Verma, Professor, Indian Institute of Technology, [...]
February 17th, 2008 by Richard Brassaw
An elevated level of a white blood cell count can indicate a major infection or a serious blood disorder such as leukemia. Now it is thought that Post Traumatic Stress Disorder (PTSD) can be just as good of an indicator of a person’s long term health status.
Joseph Boscarino, PhD, MPH, Geisinger Senior Investigator, examined the health [...]
February 16th, 2008 by Richard Brassaw
For reasons still unknown, the brain neurotransmitter serotonin is critical to the development and treatment of depression and chronic anxiety. An even a bigger mystery is why more women than men are affected by depression and chronic anxiety.
Hristina Jovanovic, Swedish medical university Karolinska Institute, believes he may be able to show why women are affected [...]
February 15th, 2008 by Richard Brassaw
Parkinson’s disease signature symptoms are tremors, rigidity, and impaired movement associated with the progressive loss of motor skills. Currently, L-DOPA is the only relief of the common symptoms experienced by Parkinson’s disease patients, but it can cause prominent side effects that counteract its effectiveness.
Paul Greengard, Rockefeller University, and colleagues in Sweden, have found evidence that [...]
February 14th, 2008 by Richard Brassaw
Major depression affects approximately 1-2% of older adults, but as many as 20% may experience symptoms of depression.
Lisa C. Barry, PhD, MPH, Yale University School of Medicine, New Haven, evaluated 754 individuals all over the age of 70. The study began in 1998, with follow-up assessments done every 18 months. Over the course of the [...]
February 13th, 2008 by Richard Brassaw
Dementia is more likely to occur in those who are older, relatively poorly educated, inactive, and have deposits of the protein ApoE. Researchers now believe the onset of dementia is significantly more likely in those with lower than usual foliate levels.
Researchers tracked the development of dementia in 518 people over 2 years (2001-2003). Participants were [...]
February 12th, 2008 by Richard Brassaw
People who have been abused as children and fortunate enough to carry a gene called corticotropin-releasing hormone receptor one (CRHR1) demonstrate less frequent depression than those abused as children who do not carry the gene.
Rebekah Bradley, PhD, Atlanta Veterans Affairs Medical Center, and Elisabeth Binder, MD, PhD, Emory University, studied more than 470 adults; which [...]
February 11th, 2008 by Richard Brassaw
Depression is an illness that can affect 20% of the people at least once during their lifetime. According to World Health Organization (WHO), by 2020 emotional state disorders, in developed countries, could be the foremost reason to leave work.
Jorge Emilo Ortega Calvio, faculty of medicine and odontology, University of the Basque Country (UPV/EHU), analyzed the current [...]
February 10th, 2008 by Richard Brassaw
Rheumatoid arthritis (RA) is estimated to have a financial impact into the tens of billions of dollars worldwide.
In recent years new rheumatoid arthritis drugs have been shown to increase the chances for remission, halting of the progression of joint damage and improve, or prevent, disability. Access to these drugs in developed countries varies greatly, with [...]